When compared to people who consumed more than 20 percent of their daily energy at breakfast, habitual breakfast skippers were at a 1.55-fold increased risk of noncoronary atherosclerosis and a 2.57-fold increased risk of generalized atherosclerosis, independent of traditional and dietary cardiovascular risk factors.

A new JAMA: Cardiology study comparing the outcomes of percutaneous coronary intervention (PCI) in black and white patients showed no difference in one-year mortality rates, but it did shed light on other racial gaps in the cardiovascular treatment process.

Middle-aged and older residents in the hardest-hit areas suffered 25 percent more cardiovascular-related deaths in the year after the Canterbury earthquakes when compared to neighbors in lesser-impacted areas.

Patients with stable coronary heart disease (CHD)—despite being considered “fit” and participating in phase III cardiac rehabilitation—demonstrated worse cognitive function when compared to healthy, age-matched individuals in a single-center study published in PLOS One.

In patients with a previous history of stroke or heart attack, discontinuation was associated with a 46 percent increased risk—translating to one additional cardiovascular event per year per 36 patients who stopped taking aspirin.

Nicotine in electronic cigarettes boosts the cardiac adrenaline levels of users, which could put them at increased risk for heart disease, according to a new study in the Journal of the American Heart Association.

Based on clinical guidelines, three therapies are often prescribed together following acute MI: angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs), beta-blockers and statins. But are they equally important?

In a large, retrospective study of the Taiwan population, researchers found individuals with retinal vein occlusion (RVO) demonstrated an adjusted risk increase of 21 percent for suffering a heart attack.